MED

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total common shares outstanding 10.94 M10.94 M10.99 M10.99 M10.99 M10.99 M — Enterprise value 94.04 M101.8 M56.44 M52.73 M50.72 M28.08 M 187.98 M Price to earnings ratio 29.4592.74-21.0642.58683.5-6.28 698.73 Price to sales ratio 0.310.320.270.320.350.3 1.25 Price to cash flow ratio 5.257.897.1736.820.7917.09 81.85 Price to book ratio 0.250.920.180.180.180.59 1.13 Enterprise value to EBITDA ratio 4.4813.1115.893.615.45-9.69 15.26 Return on assets % 0-0.0500.010.010.05 0.07 Return on equity % 0.01-0.0700.010.010.07 0.09 Return on invested capital % 8.76-50.44-9.75.1120.6151.82 167.82 Gross margin % 75.3974.1372.872.6169.5269.43 284.36 Operating margin % 1.5-12.641.091.014.5610.39 17.06 EBITDA margin % 3.783.32.082.83-0.03-5.28 -0.4 Net margin % 0.81-13.030.672.352.5317.52 23.07 Quick ratio 2.552.682.873.823.954.22 14.87 Current ratio 3.113.343.524.474.454.69 17.14 Inventory turnover —————— — Asset turnover 0.480.410.410.380.330.29 1.42 Debt to assets ratio —————— — Debt to equity ratio —————— — Long term debt to total assets ratio —————— — Long term debt to total equity ratio —————— — Operating cash flow per share 0.83-0.450.31-0.311.1-0.48 0.63 EBIT per share 0.190.07-0.08-0.1-0.32-0.68 -1.17 EBITDA per share 0.480.360.220.27-0-0.36 0.13 Total debt per share —————— — Cash per share 15.7415.1115.2714.6415.7215.15 60.78 Net current asset value per share 20.5119.5619.518.6718.9118.37 75.45 Tangible book value per share 18.919.1719.2719.5319.5318.11 76.45 Working capital per share 13.9113.713.9714.4914.6614.45 57.57 Book value per share 18.919.1719.2719.5319.5318.11 76.45